CBG is legal in the UK as long as it is within all the rules set by the food and drug administration. CBG should not contain more than 0.3% THC, which is non-intoxicating. Notably, as a standalone cannabis derivative, it has no CBG legislation in the UK. In the current article, we discuss the chemical components of CBG and their legal implications in the UK.
Like CBD, CBG is legal in many states, including the UK, as long as the THC amounts are below 0.3%. CBG is among the commonly known cannabinoid, but it is minor since it occupies only one percent of the hemp plant. However, with the development of scientific modification, the cannabis derivative is producible in larger quantities. Notably, CBD and CBG have many similarities, although they have certain differences too. The legalization of CBD has made its way into the market in different forms, including topicals, edibles, and vapes. While CBG products are relatively rare and expensive, their availability and usage have increased significantly.
What is CBG
Cannabigerol is the precursor of other prominent cannabinoids such as THC and CBD. It made its way into the market due to its health benefits. For example, CBG is effective for treating glaucoma. The cannabis derivative is more concentrated in young cannabis plants compared to fully grown ones.
CBDA is the chemical form of CBG, converted to CBD and THC upon the maturity of hemp plant. However, there are developed strains that have increased the production of CBG. For example, the white CBG, glue CBG, and jack frost CBG have more CBG compounds than others. The main reason for the cultivation of these strains is to produce CBG.
Why Is CBG Important?
Cannabinoids have medicinal and therapeutic effect on the body. However, there is no substantial scientific proof for the claimed effects of the compound. Therefore, there is need for more CBG studies on human.
Huntington’s is a health condition that results in the breakdown of brain’s nerve cells. The different medications available for Huntington’s diseases have adverse side effects, ranging from minor to severe. Lately, people are embracing organic compounds for their health issues; According to Míčka (2013), CBG has neuroprotective properties essential for preventing the damage to nerve cells.
Cannabinoids are linked to health benefits including but not limited to anti-inflammation that suppress pain and inflammation. According to Hill et al. (2016), CBG can be used in treating inflammatory bowel disease (IBD). This is a health condition characterised by severe swelling in the bowel. The condition has no cure, but research shows that patients exhibited reduced inflammation after taking CBG.
Diverse health conditions cause acute or chronic pain. Most people use proscribed painkillers like opioids to reduce pain. However, opioids are addictive; thus, most people desire to have a natural remedy for their condition. According to Überall (2020), CBG can relieve different forms of pain, including Muscles, joints, and nerve pain. Pain relief is the major reason for the infusion of CBG in products like drinks.
Fighting Cancer Cells
According to Lu et al. (2017), CBG has shown the ability to block cancer cell receptors and prevent colorectal cancer cell growth. Research shows that CBG’s neuroprotective properties can inhibit the growth of cancerous cells. Also, it is believed to treat and prevent colon cancer.
The body is exposed to many disease-causing organisms, including bacteria and fungi. There are over-the-counter antibacterial and antifungal drugs available today, and many want to use an organic compound with fewer side effects on the body. According to Aqawi et al. (2021), CBD can help treat bacterial and fungal infections due to its antibacterial and antifungal properties.CBG can fight methicillin-resistant Staphylococcus aureus (MRSA), bacteria that causes staph infections. Also, CBG can be used in treating different skin conditions, including psoriasis.
Glaucoma is an eye condition characterized by high pressure in the eyes; it might lead to blindness when left untreated. Cairns et al. (2016) observed the reduction of eye pressure and glaucoma. CBG facilitates the production of nutrition that maintain pressure.
Is CBG Legal in the UK
When the CBG compounds abide by all the rules set by the food and drug they become legal in the UK. CBG should not contain more than 0.3% of THC; this level is approved and non-intoxicating. Notably, CBG alone has no legislation in the UK.
How To Use CBG.
Due to scarcity, the oil is more expensive compared to other cannabis derivatives. However, one can enjoy its benefits through broad-spectrum CBD, which contains multiple compounds, terpenes, flavonoids, and cannabinoids. The compounds work in synergy to provide a wider range of benefits without the psychoactive effects. In its oil form, you can take it orally or topically. On the skin surface, it helps treat skin conditions like acne and eczema. This is possible since the cannabinoid can interact with the receptors in the skin to provide the desired relief.
CBDA is converted to CBG in young cannabis plants and later to CBD and THC upon the maturity of the hemp. This has made cannabis farmers cross breed and adopts genetic manipulation to produce more CBG. However, there are developed strains that have increased the production of CBG. Like CBD, CBG is legal in the UK but should contain less than 0.3% THC. There are diverse reasons why CBG is important to your body, such as anti-inflammation, anti-bacterial, and its capacity to treat glaucoma and Huntington's disease.
Aqawi, M., Sionov, R. V., Gallily, R., Friedman, M., & Steinberg, D. (2021). Antibacterial properties of cannabigerol toward Streptococcus mutans. Frontiers in Microbiology, 12, 656471.
Cairns, E. A., Baldridge, W. H., & Kelly, M. E. (2016). The endocannabinoid system is a therapeutic target in glaucoma. Neural Plasticity, 2016
Hill, L. A., Bodnar, T. S., Weinberg, J., & Hammond, G. L. (2016). Corticosteroid-binding globulin is a biomarker of inflammation onset and severity in female rats. The Journal of endocrinology, 230(2
Lu, X. S., Qiao, Y. B., Li, Y., Yang, B., Chen, M. B., & Xing, C. G. (2017). Preclinical study of cinobufagin as a promising anti-colorectal cancer agent. Oncotarget, 8(1), 988.
Míčka, T. (2013). Getting High to Get Well: Scientific Evidence of Therapeutic Uses of Cannabinoids and Terpenoids.
Überall, M. A. (2020). A review of scientific evidence for THC: CBD oromucosal spray (nabiximols) in chronic pain management. Journal of pain research, 13, 399.